SG3 Management, LLC
- SEC CIK
- 0001630888
- Latest filing
- Nov 15, 2023
APLS holding history
Apellis Pharmaceuticals, Inc. in every 13F filed by SG3 Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
APLS overviewAll 13F holders of APLSFull Q3 2023 holdings
- Shares (Q1 2023)
- 0
- Sold out in Q1 2023
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 5
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2023 | 0 | $0 | 0.0% | −22,000−100.0% | Sold out | Holders |
| Q4 2022 | 22,000 | $1.14M | 0.7% | −18,000−45.0% | Reduced | Holders |
| Q3 2022 | 40,000 | $2.73M | 1.7% | +38,845+3,363.2% | Added | Holders |
| Q2 2022 | 1,155 | $52.0K | 0.1% | +1,155 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −100,000−100.0% | Sold out | Holders |
| Q3 2021 | 100,000 | $3.30M | 1.2% | +90,000+900.0% | Added | Holders |
| Q2 2021 | 10,000 | $632.0K | 0.3% | +10,000 | New | Holders |